Literature DB >> 16096893

Outpatient use of systemic antibiotics in croatia.

D Stimac1, I Vukusić, J Culig.   

Abstract

OBJECTIVE: The aim was to estimate the outpatient utilization of antibacterials for systemic use in Zagreb, Croatia, and to define the antibiotic utilization characteristics and consequences.
METHOD: Using the WHO ATC/DDD methodology, the number of defined daily doses per 1000 inhabitants per day (DDDs/TID) was calculated for each individual antibiotic and ATC system levels were calculated from data collected on the number and size of packages prescribed and dispensed from pharmacies. The Drug Utilization 90% (DU90%) method was used to evaluate the quality of drug prescribing.
RESULTS: The total utilization of antibiotics was found to be extremely high, 55.0 DDDs/TID. The leading antibiotic was amoxicillin + clavulanic acid with 14.7 DDDs/TID. Penicillins accounted for the highest utilization (46.3%) expressed in DDDs/TID (25.4), followed by cephalosporins and macrolides 25 and 12.5% of utilization, respectively expressed in DDDs/TID), tetracyclines, quinolones, aminoglycosides and other agents. Nine of 27 antibiotics fell within the DU90% segment. The cost/DDD foldrugs within DU90% segment was 1.2 EUR, for drugs beyond DU90% segment was 1.4 EUR, and the average was 1.2 EUR.
CONCLUSION: Irrational prescribing and preference to more expensive drugs have been reported in Zagreb. Therefore, the risk of resistance of microorganisms to beta-lactamase antibiotics, macrolides and quinolones could be expected. Prescribing patterns should be changed by introducing national guidelines on rational antibiotic prescribing, monitoring and evaluation of their implementation. Additional continuing education of physicians and pharmacists from independent sources should be organized and proper education should be provided to patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096893     DOI: 10.1007/s11096-004-3704-z

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  12 in total

1.  Non-hospital consumption of antibiotics in Spain: 1987-1997.

Authors:  A R Bremón; M Ruiz-Tovar; B P Gorricho; P D de Torres; R L Rodríguez
Journal:  J Antimicrob Chemother       Date:  2000-03       Impact factor: 5.790

2.  Variation in antibiotic use in the European Union.

Authors:  O Cars; S Mölstad; A Melander
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

3.  Quality assessment of drug sales data: the case of antibacterials in Iceland.

Authors:  I Björnsdóttir; E H Hansen; A Grímsson
Journal:  Pharm World Sci       Date:  1999-10

Review 4.  Comparison of dose standard units for drug utilisation studies.

Authors:  J Merlo; A Wessling; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

5.  Drug utilization 90%--a simple method for assessing the quality of drug prescribing.

Authors:  U Bergman; C Popa; Y Tomson; B Wettermark; T R Einarson; H Aberg; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1998-04       Impact factor: 2.953

6.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

Authors:  D J Austin; K G Kristinsson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

7.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

8.  Consumption of anti-infective drugs in Bulgaria for the period from 1979 to 1994.

Authors:  M Popova; P Popova; G Guencheva
Journal:  Pharm World Sci       Date:  1997-04

9.  Application of the ATC/DDD methodology to monitor antibiotic drug use.

Authors:  S Natsch; Y A Hekster; R de Jong; E R Heerdink; R M Herings; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

10.  Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).

Authors:  Vera Vlahovic-Palcevski; Björn Wettermark; Ulf Bergman
Journal:  Eur J Clin Pharmacol       Date:  2002-04-26       Impact factor: 2.953

View more
  2 in total

1.  Outpatient use of systemic antibiotics in Croatia.

Authors:  M Ferech; A Andrasevic; S Coenen; I Francetic; H Goossens
Journal:  Pharm World Sci       Date:  2006-04-28

2.  Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District, Serbia, and Some Scandinavian Countries?

Authors:  Olga Horvat; Vesna Mijatović; Boris Milijasević; Ana Tomas; Milica Paut Kusturica; Zdenko Tomić; Ana Sabo
Journal:  Front Public Health       Date:  2018-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.